The results suggested that the combination blockade of the PD-1/PD-L1- and CTLA-4-negative co-stimulatory pathways allowed tumor-specific T cells that would otherwise be inactivated to continue to expand and carry out effector functions, thereby shifting the tumor microenvironment from suppressive to inflammatory (60). Here, CD274 is linked to neoplasm.